Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation

Kidney International, Supplement

Volumn 64, Issue 86, 2003, Pages

  Sánchez Lozada, Laura G ^b   Tapia, Edilia ^b   Johnson, Richard J ^b   Rodríguez Iturbe, Bernardo ^b   Herrera Acosta, Jaime ^a  

^a Laboratory of Renal Physiopathology   (Mexico)

^b NONE

Author keywords

Arteriolopathy; Glomerular hypertension; Inflammation; Tubulointerstitial injury

Indexed keywords

ALBUMIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN;

BLOOD VESSEL INJURY; CAPILLARY WALL; CONFERENCE PAPER; GLOMERULUS; GLOMERULUS CAPILLARY; HEMODYNAMICS; HYPERTENSION; HYPERURICEMIA; INTERSTITIAL NEPHRITIS; KIDNEY ARTERY; KIDNEY BLOOD FLOW; KIDNEY PLASMA FLOW; KIDNEY TUBULE PRESSURE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TISSUE PRESERVATION; ALBUMINURIA; ANIMAL; ARTERIOLE; KIDNEY TUBULE; METHODOLOGY; NEPHRECTOMY; NEPHRITIS; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; VASCULARIZATION;

ALBUMINURIA; ANIMALS; ARTERIOLES; HEMODYNAMIC PHENOMENA; HYPERURICEMIA; KIDNEY GLOMERULUS; KIDNEY TUBULES; NEPHRECTOMY; NEPHRITIS;

EID: 3142682913     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.64.s86.3.x     Document Type: Conference Paper

References (52)

1. HOSTETTER TH, OLSON JL, RENNKE HG, et al: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol Renal Physiol 241:F85-F93, 1981
2. RUGGENENTI P, REMUZZI G: The role of protein traffic in the progression of renal diseases. Annu Rev Med 51:315-327, 2000
3. BRENNER BM: Remission of renal disease: Recounting the challenge, acquiring the goal. J Clin Invest 110:1753-1758, 2002
4. BAKRIS GL, WILLIAMS M, DWORKIN L, et al: Preserving renal function in adults with hypertension and diabetes: A consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 36:646-661, 2000
5. YOSHIDA Y, KAWAMURA T, IKOMA M, et al: Effects of antihypertensive drugs on glomerular morphology. Kidney Int 36:626-635, 1989
6. ANDERSON S, MEYER TW, RENNKE HG, et al: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612-619, 1985
7. MAYER G, LAFAYETTE RA, OLIVER J, et al: Effects of angiotensin II receptor blockade on remnant glomerular permselectivity. Kidney Int 43:346-353, 1993
8. LAFAYETTE RA, MAYER G, PARK SK, et al: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90:766-771, 1992
9. BRENNER BM, COOPER ME, DE ZEEUW D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869, 2001
10. ABBATE M, ZOJA C, CORNA D, et al: In progressive nephropathies, overload of tubular cells with fitered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 9:1213-1224, 1998
11. FINE LG, ORPHANIDES C, NORMAN JT: Progressive renal disease: The chronic hypoxia hypothesis. Kidney Int 53(Suppl 65):S74-S78, 1998
12. BOTTINGER EP, BITZER M: TGF-beta signaling in renal disease. J Am Soc Nephrol 13:2600-2610, 2002
13. MÜLLER DN, DECHEND R, MERVAALA EMA, et al: NF-κB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertens 35:193-201, 2000
14. MÜLLER DN, HEISSMEYER V, DECHEND R, et al: Aspirin inhibits NF-κB and protects from angiotensin II-induced organ damage. FASEB J 15:1822-1824, 2001
15. FUJIHARA CK, MALHEIROS DM, ZATZ R, et al: Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int 54:1510-1519, 1998
16. ROMERO F, RODRÍGUEZ-ITURBE B, PARRA G, et al: Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats. Kidney Int 55:945-955, 1999
17. FUJIHARA CK, NORONHA ID, AVANCINI DM, et al: Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney. J Am Soc Nephrol 11:283-290, 2000
18. MAZZALI M, HUGHES H, KIM YG, et al: Elevated uric acid increases blood pressure in the rat by a novel crystal independent mechanism. Hypertens 38:1101-1106, 2001
19. EDDY AA, GIACHELLI CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47:1546-1557, 1995
20. LARGO R, GÓMEZ-GARRE D, SOTO K, et al: Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertens 33:732-739, 1999
21. GÓMEZ-GARRE D, LARGO R, TEJERA N, et al: Activation of NF-kB in tubular epithelial cells of rats with intense proteinuria. Role of angiotensin II and endothelin-1. Hypertens 37:1171-1178, 2001
22. ZOJA C, DONADELLI R, COLLEONI S, et al: Protein overload stimulated RANTES production by proximal tubular cells depending on NF-kB activation. Kidney Int 53:1608-1615, 1998
23. TAKASE O, HIRASHI J, TAKAYANAGI A, et al: Gene transfer of truncated IkBa prevents tubulointerstitial injury. Kidney Int 63:501-513, 2003
24. ALVAREZ V, QUIROZ Y, NAVA M, et al: Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol Renal Physiol 283:F1132-F1141, 2002
25. BOHLE A, KRESSEL G, MULLER CA, et al: The pathogenesis of chronic renal failure. Pathol Res Pract 185:421-440, 1989
26. BOHLE A, MACKENSEN-HAEN S, VON GISE H, et al: The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract 186:135-144, 1990
27. BECKER GJ, HEWITSON TD: The role of tubulointerstitial injury in chronic renal failure. Curr Opin Nephrol Hypertens 9:133-138, 2000
28. GANDHI M, OLSON JL, MEYER TW: The contribution of tubular injury to loss of remnant kidney function. Kidney Int 54:1157-1165, 1998
29. MEYER TW: Tubular injury in glomerular disease. Kidney Int 63:774-787, 2003
30. FUJIHARA CK, MALHEIROS DMAC, DONATO JL, et al: Nitroflurbiprofen, a new nonsteroidal anti-inflammatory, ameliorates structural injury in the remnant kidney. Am J Physiol Renal Physiol 274:F573-F579, 1998
31. BOBADILLA NA, TACK I, TAPIA E, et al: Pentosan polysulfate prevents glomerular hypertension and structural injury despite persisting hypertension in 5/6 nephrectomy rats. J Am Soc Nephrol 12:2080-2087, 2001
32. REMUZZI G, ZOJA C, GAGLIARDINI E, et al: Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals. J Am Soc Nephrol 10:1542-1549, 1999
33. LIN SH, CHEN YM, CHEN CT, et al: Pentoxifylline attenuated the renal disease progression in rats with remnant kidney. J Am Soc Nephrol 13:2916-2929, 2002
34. ALLISON AC, EUGUI EM: Mycophenolate mofetil: A rationally designed immunosuppressive drug. Clin Transplant 7:96-112, 1993
35. TAPIA E, FRANCO M, SÁNCHEZ-LOZADA LG, et al: Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal renal ablation. Kidney Int 63:994-1002, 2003
36. GONICK HC, RUBINI MD, GLEASON O, et al: The renal lesion in gout. Ann Int Med 62:667-674, 1965
37. MAZZALI M, KANELLIS J, HAN L, et al: Hyperuricemia induces a primary arteriolopathy in rats by a blood pressure independent mechanism. Am J Physiol Renal Physiol 282:F991-F997, 2002
38. RAO GN, CORSON MA, BERCK BC: Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet derived growth factor A-chain expression. J Biol Chem 266:8604-8608, 1991
39. SÁNCHEZ-LOZADA LG, TAPIA E, AVILA-CASADO C, et al: Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 283:F1105-F1110, 2002
40. KANG DH, NAKAWAGA T, FENG L, et al: A role of uric acid in renal disease. J Am Soc Nephrol 13:2888-2897, 2002
41. TANG S, LEUNHG JCK, ABE K, et al: Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 111:515-527, 2003
42. YANG CW, AHN HJ, KIM WY, et al: Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy. Transplantation 75:309-315, 2003
43. KREISBERG JI, KARNOVSKY MJ: Focal glomerular sclerosis in the fawn-hooded rat. Am J Physiol 92:637-652, 1978
44. SIMONS JL, PROVOOST AP, ANDERSON S, et al: Pathogenesis of glomerular injury in the fawn-hooded rat: Early glomerular capillary hypertension predicts glomerular sclerosis. J Am Soc Nephrol 3:1775-1782, 1993
45. WEICHERT W, PALIEGE A, PROVOOST AP, et al: Upregulation of juxtaglomerular NOS-1 and COX-2 precedes glomerulosclerosis in fawn-hooded hypertensive rats. Am J Physiol Renal Physiol 280:F706-F714, 2001
46. SIMONS JL, PROVOOST AP, ANDERSON S, et al: Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury. Kidney Int 46:396-404, 1994
47. KOMATSU K, FROLICH ED, ONO H, et al: Glomerular dynamics and morphology of aged spontaneously hypertensive rats. Effects of angiotensin-converting enzyme inhibition. Hypertens 25:207-213, 1995
48. LUFT FC: Mechanisms and cardiovascular damage in hypertension. Hypertens 37:594-598, 2001
49. TOUYZ RM, HE G, EL MABROUK M, et al: p38 MAP kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY. Hypertens 37:574-580, 2001
50. MEYRIER A, HILL GS, SIMON P: Ischemic renal diseases: New insights into old entities. Kidney Int 54:2-13, 1998
51. KANG DH, JOHNSON RJ: Vascular endothelial growth factor: A new player in the pathogenesis of renal fibrosis. Curr Opin Nephrol Hypertens 12:43-49, 2003
52. KANG DH, NAKAGAWA T, FENG L, et al: Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol 61:239-248, 2002